InsidersTradesSigma
Discover the full record of transactions filed by Iris Loew-Friedrich, Director. Insider active across 2 companies, notably Swedish Orphan Biovitrum AB (publ). Aggregated, 1 reports have been published. Activity tracked since 10 February 2026. The latest transaction was disclosed on 10 February 2026 (Purchase). Regulator: FIN-FSA. All data is openly available.
1 of 1 declaration
Iris Loew-Friedrich is a board member of Swedish Orphan Biovitrum AB. In this role, she participates in strategic discussions and decision-making within the board. Iris brings expertise in the pharmaceutical sector, thus contributing to the strategic direction of the company. Her commitment to ethics and accountability is an asset for Swedish Orphan Biovitrum.